Jin Tian

1PUBLICATIONS
0CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Feb 08, 2022
LAG-3 is a promising inhibitory immune checkpoint for antitumor immunotherapy.

Jin Tian, Yang Liu, TengLong Zhang

Pageof 1

Frequent Collaborators